>
Iran Announces Fuel Rationing As Brent Sets New War Highs, After Trump Rejects Tehran's Latest O
BREAKING: James Comey Under Arrest – Surrenders to Law Enforcement at Federal Courthouse...
Founding Felons: Jefferson Would Be on a Watch List Today--You Might Be Next
If Science Is a Public Good, Let China Pay for It
Researcher wins 1 bitcoin bounty for 'largest quantum attack' on underlying tech
Interceptor-Drone Arms-Race Emerges
A startup called Inversion has introduced Arc, a space-based vehicle...
Mining companies are using cosmic rays to find critical minerals
They regrew a severed nerve - by shortening a bone.
New Robot Ants Work Like Real Insects To Build And Dismantle On Their Own
Russian scientists 'are developing the world's first drug to delay ageing' months after
Sam Altman's World ID Expands Biometric Identity Checks
China Tests Directed Energy Beam That Recharges Drones Mid-Flight
Jurassic Park might arrive sooner than expected, just with Dinobots.

Retinitis pigmentosa (RP) is a genetic eye condition that results in damage to the retina. It has no cure; over time, a person with RP loses much or all of their vision.
But scientists have gotten one step closer to finding a better treatment. Researchers at the RIKEN Institute in Japan have now succeeded in growing retinal tissue and transplanting that tissue into the retinas of rhesus monkeys with RP. Three weeks after the treatment, visual tests on two of the monkeys found their vision had improved.
In the study, published this week in the journal PNAS, researchers grew retinal tissue from stem cells and then transplanted the tissue into the retinal area of rats with advanced RP. The tissue grew and in some cases adhered to the cells already in the retina and formed connections—a key factor in the success of this approach.